QSI
Quantum-Si incorporated
There isn't enough reported data to score QSI yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
QSI Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Under pressure | |
| Unavailable |
QSI's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
QSI PE Valuation
QSI has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
QSI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect QSI's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
QSI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.38 | +$0.29 |
| Q2 2026 | -$0.45 | +$0.23 |
| Q1 2026 | -$0.50 | +$0.18 |
| Q4 2025 | -$0.51 | +$0.20 |
| Q3 2025 | -$0.67 | -$0.03 |
| Q2 2025 | -$0.68 | -$0.05 |
| Q1 2025 | -$0.68 | -$0.03 |
| Q4 2024 | -$0.71 | -$0.03 |
QSI is still losing money, but far less than before: $0.38 per share over the past year, against $0.95 at its worst in late 2022.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over QSI on earnings quality, reporting a profit while its opponent remains loss making.
QSI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $212K | -62% |
| Q2 2026 | $344K | -42% |
| Q1 2026 | $258K | -69% |
| Q4 2025 | $451K | -62% |
| Q3 2025 | $552K | -30% |
| Q2 2025 | $591K | -5% |
| Q1 2025 | $842K | +84% |
| Q4 2024 | $1.2M | +198% |
QSI's revenue has slid since its 2024 peak: $212,000 last quarter, down 62% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -11215% | -4010 points |
| Q2 2026 | -7450% | -2354 points |
| Q1 2026 | -9323% | -6341 points |
| Q4 2025 | -4677% | -2104 points |
| Q3 2025 | -7205% | -3636 points |
| Q2 2025 | -5096% | -844 points |
| Q1 2025 | -2982% | +2129 points |
| Q4 2024 | -2574% | +4397 points |
QSI's operating margin was −11215% last quarter, down 4010 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over QSI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over QSI on profitability, with a higher operating margin.
QSI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$20.6M | +$12.3M |
| Q2 2026 | -$18.5M | +$2M |
| Q1 2026 | -$25.9M | +$1.5M |
| Q4 2025 | -$16.3M | +$8M |
| Q3 2025 | -$32.9M | -$8.8M |
| Q2 2025 | -$20.5M | -$844K |
| Q1 2025 | -$27.5M | -$3.2M |
| Q4 2024 | -$24.3M | -$3.7M |
QSI has burned cash in almost every quarter: −$81M over the past year, against −$105M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over QSI on cash generation, producing positive trailing cash flow while its opponent burns cash.
QSI Net Leverage
QSI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
QSI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.9 | Neutral |
| Stochastic | 57.2 | Neutral |
QSI's weekly RSI is 54 (neutral) and its Stochastic is 57 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
QSI PE vs Healthcare Sector
QSI has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
QSI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.31 | 6.9% below |
| 20 week MA | $1.00 | 22% above |
| 50 week MA | $1.02 | 20% above |
| 100 week MA | $1.36 | 10% below |
| 200 week MA | $1.48 | 18% below |
QSI's trend is mixed: it's above two of its five weekly moving averages, and 18% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over QSI on trend strength, trading above more of its moving averages.
QSI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.88 | $10.2 | +3% |
| 2021 | $10.2 | $8.16 | -20% |
| 2022 | $8.16 | $2.07 | -75% |
| 2023 | $2.07 | $2.01 | -2.9% |
| 2024 | $2.01 | $3.60 | +79% |
| 2025 | $3.60 | $1.23 | -66% |
| 2026 YTD | $1.23 | $1.22 | -0.8% |
QSI has finished lower in four of the last six years. It's down 0.8% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over QSI on returns for 2026, with the stronger performance.